This is my opinion, but drug companies need to study pregnancy and not have it shelved off as a contraindication as it is very important, Hynes said
According to Novo Nordisk, a 64-week clinical trial with over 300 participants found that those with obesity or overweight who took the oral Wegovy pill once a day lost an average of 16.6% of their body weight for people who completed the trial, a similar amount to those who took the injectable form of Wegovy, which launched in 2021, on a weekly basis
In fact, studies show that digestive enzymes can actually enhance the benefits of GLP-1s by improving nutrient absorption without interfering with delayed gastric emptying
doi:10.1056/NEJMoa2028198 8
WW Clinic offers GLP-1 medication to eligible people to help them lose weight
After the FDA determined that the semaglutide shortage (February 2025) and tirzepatide shortage (October 2024) were resolved, enforcement of compounding restrictions changed significantly